Authors
John Michael O’Brien, PharmD, MPH, is president and CEO of the National Pharmaceutical Council.
ORCID ID: 0009-0003-1578-2500
Medical director, Asklepios Tumour Biology Centre
Advertisement
Advertisement
Trending on AJMC
1
Judge Denies Preliminary Injunction in Medicaid Work Requirements Case
2
AHRQ Grant Freeze Halts Patient Safety Research Nationwide
3
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
4
MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds
5

